Share:
Share this content in WeChat
X
Review
Research progress and prospect of DCE-MRI in breast lesions with rim enhancement
LI Xiaoxiao  JIANG Xingyue 

Cite this article as: Li XX, Jiang XY. Research progress and prospect of DCE-MRI in breast lesions with rim enhancement[J]. Chin J Magn Reson Imaging, 2022, 13(2): 148-151. DOI:10.12015/issn.1674-8034.2022.02.037.


[Abstract] Breast disease is common in women, and the dynamic contrast enhanced magnetic resonance imaging plays an important role in clinical diagnosis. In breast MRI examination, rim enhancement as a common enhancement mode, can be seen in a wide range of benign and malignant breast lesions, and is easy to be misdiagnosed clinically. At present, there are few studies on the rim-enhancing lesions on breast MRI. In this paper, the MRI manifestations and pathological features, hemodynamic characteristics and functional imaging of breast rim enhanced lesions were reviewed. Meanwhile, the feasibility of magnetic resonance spectroscopy, diffusion kurtosis imaging and radiomics for diagnostic application were prospected and analyzed in this paper.
[Keywords] breast;rim enhancement;magnetic resonance imaging;dynamic contrast enhanced;differential diagnosis

LI Xiaoxiao   JIANG Xingyue*  

Department of Radiology, Binzhou Medical University Hospital, Binzhou 256603, China

JIANG XY, E-mail: xyjiang188@sina.com

Conflicts of interest   None.

Received  2021-09-23
Accepted  2021-12-28
DOI: 10.12015/issn.1674-8034.2022.02.037
Cite this article as: Li XX, Jiang XY. Research progress and prospect of DCE-MRI in breast lesions with rim enhancement[J]. Chin J Magn Reson Imaging, 2022, 13(2): 148-151.DOI:10.12015/issn.1674-8034.2022.02.037

[1]
Jinguji M, Kajiya Y, Kamimura K, et al. Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors[J]. Breast Cancer, 2006, 13(1): 64-73. DOI: 10.2325/jbcs.13.64.
[2]
Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors[J]. Radiology, 2000, 217(3): 841-848. DOI: 10.1148/radiology.217.3.r00dc07841.
[3]
Kuhl CK. Concepts for differential diagnosis in breast MR imaging[J]. Magn Reson Imaging Clin N Am, 2006, 14(3): 305-328. DOI: 10.1016/j.mric.2006.07.002.
[4]
Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study[J]. Lancet, 2007, 370(9586): 485-492. DOI: 10.1016/s0140-6736(07)61232-x.
[5]
Xu L, Wang L, Xu DZ, et al.Multimodality MRI in diagnosis of breast lesions with ring enhancement[J]. Chin J Med Imaging Technol, 2017, 33(11): 1661-1665. DOI: 10.13929/j.1003-3289.201702006.
[6]
Yang J, Su DK, Zhao X, et al.The Diagnostic Value of Combining Dynamic Contrast Enhanced MRI and Diffusion Weighted Imaging in Breast Lesions with Peripheral Enhancement[J]. J Clin Radiol, 2016, 35(10): 1490-1494.
[7]
Schmitz AM, Loo CE, Wesseling J, et al. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype[J]. Breast Cancer Res Treat, 2014, 148(3): 541-551. DOI: 10.1007/s10549-014-3170-9.
[8]
Kobayashi M, Kawashima H, Matsui O, et al. Two different types of ring-like enhancement on dynamic MR imaging in breast cancer: correlation with the histopathologic findings[J]. J Magn Reson Imaging, 2008, 28(6): 1435-1443. DOI: 10.1002/jmri.21622.
[9]
Narisada H, Aoki T, Sasaguri T, et al. Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma[J]. AJR Am J Roentgenol, 2006, 187(2): 297-306. DOI: 10.2214/ajr.05.0696.
[10]
Teifke A, Behr O, Schmidt M, et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis[J]. Radiology, 2006, 239(2): 351-360. DOI: 10.1148/radiol.2392050205.
[11]
Wang L, Wang D, Fei X, et al. A rim-enhanced mass with central cystic changes on MR imaging: how to distinguish breast cancer from inflammatory breast diseases?[J]. PLoS One, 2014, 9(3): e90355. DOI: 10.1371/journal.pone.0090355.
[12]
Liao H, Zhao Y, Ding QL, et al. Application value of apparent diffusion coefficient and its ratios of fluid and solid areas in breast rim enhancement lesions[J]. J Pract Radiol, 2021, 37(8): 1281-1285. DOI: 10.3969/j.issn.1002-1671.2021.08.014.
[13]
Mei A, Hua J. Dynamic Contrast-Enhanced MR Imaging Manifestations of Breast Lesions with Peripheral Enhancement[J]. J Pract Radiol, 2011, 27(1): 62-65. DOI: 10.3969/j.issn.1002-1671.2011.01.016.2011.01.016.
[14]
Uematsu T, Kasami M, Nicholson BT. Rim-enhancing breast masses with smooth or spiculated margins on magnetic resonance imaging: histopathology and clinical significance[J]. Jpn J Radiol, 2011, 29(9): 609-614. DOI: 10.1007/s11604-011-0612-8.
[15]
Yin Q. The diagnostic value of MRI multi-parameter combination for breast lesions with ring enhancement[J]. J Buon, 2019, 24(2): 509-515.
[16]
Wang LJ, Wang DB, Luo R, et al. Differential Diagnosis for Clustered Ring Enhancement Lesions on Breast MRI[J]. J Clin Radiol, 2018, 37(10): 1636-1641.
[17]
Trimboli RM, Carbonaro LA, Cartia F, et al. MRI of fat necrosis of the breast: the "black hole" sign at short tau inversion recovery[J]. Eur J Radiol, 2012, 81(4): e573-e579. DOI: 10.1016/j.ejrad.2011.06.048.
[18]
Shao Z, Wang H, Li X, et al. Morphological distribution and internal enhancement architecture of contrast-enhanced magnetic resonance imaging in the diagnosis of non-mass-like breast lesions: a meta-analysis[J]. Breast J, 2013, 19(3): 259-268. DOI: 10.1111/tbj.12101.
[19]
Wedegärtner U, Bick U, Wörtler K, et al. Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria[J]. Eur Radiol, 2001, 11(9): 1645-1650. DOI: 10.1007/s003300100885.
[20]
Morris EA, Comstock CE, Lee CH, et al. ACR BI-RADS magnetic resonance imaging. In: ACR BI-RADS®Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology; 2013.
[21]
Li JY, Zhao DJ. MRI advances in imaging diagnosis of breast non-mass enhancement lesions[J]. Chin J Med Imag, 2018, 26(7): 547-551. DOI: 10.3969/j.issn.1005-5185.2018.07.019.
[22]
Dietrich O, Biffar A, Baur-Melnyk A, et al. Technical aspects of MR diffusion imaging of the body[J]. Eur J Radiol, 2010, 76(3): 314-322. DOI: 10.1016/j.ejrad.2010.02.018.
[23]
Xu JR. Advances and challenges of MRI in breast[J]. Chin J Magn Reson Imaging, 2017, 8(3): 161-163. DOI: 10.12015/issn.1674-8034.2017.03.001.
[24]
Ke CL, Li J. Magnetic resonance diffusion imaging: Clinical research progress of IVIM and DKI in breast lesions[J]. Chin J Magn Reson Imaging, 2018, 9(2): 153-156. DOI: 10.12015/issn.1674-8034.2018.02.015.
[25]
Guan XQ, Li HL, Fang J, et al. Application of the diffusion kurtosis imaging for the study of breast lesions: Meta-analysis[J]. J Pract Radiol, 2018, 34(10): 1534-1537, 1552. DOI: 10.3969/j.issn.1002-1671.2018.10.013.
[26]
Lin Y, Huang Y, Lin WX, et al. Evaluation of diffusion kurtosis imaging and its combination with diffusion weighted imaging and proton MR spectroscopy in differentiation of breast lesions[J]. Chin J Radiol, 2017, 51(5): 350-354. DOI: 10.3760/cma.j.issn.1005-1201.2017.05.006.
[27]
Christou A, Ghiatas A, Priovolos D, et al. Accuracy of diffusion kurtosis imaging in characterization of breast lesions[J]. Br J Radiol, 2017, 90(1073): 20160873. DOI: 10.1259/bjr.20160873.
[28]
Li T, Lu LB, Zhuo YY, et al. Diagnostic value of diffusion kurtosis imaging combined with quantitative dynamic contrast-enhanced MRI in breast lesions[J]. Chin J Radiol, 2018, 52(6): 436-441. DOI: 10.3760/cma.j.issn.1005-1201.2018.06.006.
[29]
Guo ZZ, Feng W, Liu HF, et al. Application progress and technical limits of 1H-MRS in breast cancer [J]. Chin J Med Imag, 2020, 28(9): 709-712. DOI: 10.3969/j.issn.1005-5185.2020.09.018.
[30]
Lu ZY, Zhang H, Yue MY, et al. Research progress of 1H-MRS in breast cancer[J]. Chin J Magn Reson Imaging, 2021, 12(1): 112-114. DOI: 10.12015/issn.1674-8034.2021.01.027.
[31]
Li H, Feng YH, Tai ZQ, et al. Application of MR Spectral Parameters and DWI in the Diagnosis of Benign and Malignant Breast Lesions[J]. Chin J CT & MRI, 2021, 19(1): 98-100. DOI: 10.3969/j.issn1672-5131.2021.01.034.
[32]
Luo YH. Diagnosis of Breast Imaging[M]. Shenyang: Liaoning Science and Technology Publishing House, 2016, 2: 21-22.
[33]
Liu T, Sheng XL, Gao Y, et al. Application progress of MR radiomics in neoadjuvant chemotherapy for breast cancer[J]. Chin J Magn Reson Imaging, 2021, 12(7): 117-120. DOI: 10.12015/issn.1674-8034.2021.07.028.
[34]
Cui CZ, Kang ZQ, Wu HH. Research progress of MRI radiomics in diagnosis and treatment of breast cancer[J]. J Pract Radiol, 2021, 37(6): 1025-1027, 1043. DOI: 10.3969/j.issn.1002-1671.2021.06.038.
[35]
Xie TW, Peng WJ. MRI radiomics in breast cancer[J]. Oncoradiology, 2021, 30(2): 135-139. DOI: 10.19732/j.cnki.2096-6210.2021.02.014.
[36]
Wang ZY, Mao N, Xie HZ. Research progress of radiomics based on MRI in breast cancer[J]. Chin J Magn Reson Imaging, 2021, 12(1): 109-111. DOI: 10.12015/issn.1674-8034.2021.01.026.

PREV Research status and potential of multi-parameter breast MRI
NEXT Advances in imaging studies of nipple-areola complex involvement
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn